Re: Cognition Health, a leading medical group who work in partnership with the Brain Injury Group, are participating in the final phase of a clinical trial for a ground-breaking drug starting in July 2013 in Greater London. The drug is designed to halt the progression of memory loss and they are currently enrolling participants for the study. The trial is free of charge but only a limited number of places are available.
How do I join the trial?
- You just need to send an email as soon as possible to clinician@re-cognitionhealth.com to register for more information
- They will contact you in the next few weeks to check that you are eligible for the study
- If you are eligible and would like to proceed, they will arrange an appointment for you to attend one of their Centres. These appointments will be taking place from late June this year in London, Guildford, Windsor, and Buckhurst Hill
Why is this opportunity so important?
- Because memory problems are not a normal part of ageing. Everyone, of any age, can be forgetful occasionally, but on-going memory problems shouldn’t be ignored as early identification of the cause can improve the outlook in most cases
- Most importantly, for progressive causes of memory loss, there are now new medications which can enhance memory and may even stop or reverse damage to the brain. These new medicines are not yet available from your GP, but one of the drugs closest to being publicly available can be accessed now through this clinical trial
You can find out more about Re:cognition Health here http://www.re-cognitionhealth.com/
